Hepatitis B Virus

Polymorphisms affect hepatitis B virus clearance and hepatocellular carcinoma

Published in Hepatitis Weekly, August 21st, 2006

According to a study from South Korea, IGF2 polymorphisms are associated with hepatitis B virus (HBV) clearance and hepatocellular carcinoma (HCC).

"The aim of this study was to determine whether IGF2 polymorphisms are associated with the clearance of HBV infection and the risk of HCC. A total of 1095 Korean subjects were prospectively enrolled in this case-control study," wrote Y.J. Kim and colleagues, Seoul National University.

"The rates of IGF2 polymorphisms were determined in each group. The IGF2 + 820E allele (IGF2 + 820G/G) and the IGF2 + 6815A/A genotype were strongly associated with the resolution of HBV infection (OR=.62-.73; p=.001-.03 and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2006-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry